← Open Payments lookup

FEMI OMIDIRE: Open Payments

NPI 1235760984 · IRVINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$398 in 30 payments from 6 companies in 2025. Trend: 2023 $918 · 2024 $586 · 2025 $398

Food & beverage: $398
CompanyPaymentsAmount
ABBVIE INC.20$234
Janssen Pharmaceuticals, Inc4$64
Braeburn Inc.3$48
Alkermes, Inc.1$18
E.R. Squibb & Sons, L.L.C.1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: VRAYLAR, INVEGA SUSTENNA, BRIXADI, ARISTADA, COBENFY, CAPLYTA.

Industry payments across NJ — which companies pay providers there.